Screening for Non-Alcoholic Fatty Liver Disease (NAFLD) in a General Practitioner Population, in Flanders, Belgium.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Non-Alcoholic Fatty Liver Disease
- Sponsor
- Hasselt University
- Enrollment
- 10000
- Locations
- 1
- Primary Endpoint
- CLDQ-NAFLD
- Status
- Active, not recruiting
- Last Updated
- 5 months ago
Overview
Brief Summary
In the Belgian adult population more than half, and numbers are still increasing, of the population is overweight or obese. These people are at risk to develop NAFLD. However, we lack epidemiological data in Belgium. Therefore, it is important to do epidemiological studies to investigate NAFLD prevalence and disease severity based on a non-invasive approach and evaluate how patients are to be referred.
Investigators
Geert Robaeys
Principal Investigator
Hasselt University
Eligibility Criteria
Inclusion Criteria
- •18 years or older,
- •able to understand Dutch,
- •able to understand the informed consent
Exclusion Criteria
- •secondary causes of steatosis
- •excessive alcohol abuse
Outcomes
Primary Outcomes
CLDQ-NAFLD
Time Frame: baseline
The determination of the prevalence of NAFLD in a general population in Flanders, Belgium by using A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
36-Item Short Form Survey (SF-36)
Time Frame: baseline
SF-36 is a set of generic, coherent, and easily administered quality-of-life measures. These measures rely upon patient self-reporting and are now widely utilized by managed care organizations and by Medicare for routine monitoring and assessment of care outcomes in adult patients.